{
    "organizations": [],
    "uuid": "f76e2cee92f2b22b502dd80c9a37b7aaff872542",
    "author": "",
    "url": "https://www.reuters.com/article/brief-nanostring-and-rikengenesis-announ/brief-nanostring-and-rikengenesis-announce-partnership-to-commercialize-ncounter-based-diagnostic-assays-in-japan-idUSFWN1OY0RH",
    "ord_in_thread": 0,
    "title": "BRIEF-NanoString And RikenGenesis Announce Partnership To Commercialize Ncounter-Based Diagnostic Assays In Japan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 4, 2018 / 11:19 AM / Updated 18 minutes ago BRIEF-NanoString And RikenGenesis Announce Partnership To Commercialize Ncounter-Based Diagnostic Assays In Japan Reuters Staff \nJan 4 (Reuters) - Nanostring Technologies Inc: \n* NANOSTRING AND RIKENGENESIS ANNOUNCE PARTNERSHIP TO COMMERCIALIZE NCOUNTER-BASED DIAGNOSTIC ASSAYS IN JAPAN \n* NANOSTRING -‍ UNDER AGREEMENT, CO, RIKEN GENESIS TO COLLABORATE TO REGISTER, OBTAIN REIMBURSEMENT, COMMERCIALIZE COMPANION DIAGNOSTIC ASSAYS IN JAPAN​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-04T13:19:00.000+02:00",
    "crawled": "2018-01-04T13:49:14.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "updated",
        "minute",
        "ago",
        "rikengenesis",
        "announce",
        "partnership",
        "commercialize",
        "diagnostic",
        "assay",
        "japan",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "nanostring",
        "technology",
        "inc",
        "nanostring",
        "rikengenesis",
        "announce",
        "partnership",
        "commercialize",
        "diagnostic",
        "assay",
        "japan",
        "nanostring",
        "agreement",
        "co",
        "riken",
        "genesis",
        "collaborate",
        "register",
        "obtain",
        "reimbursement",
        "commercialize",
        "companion",
        "diagnostic",
        "assay",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}